316 related articles for article (PubMed ID: 27881386)
1. PPARα augments heart function and cardiac fatty acid oxidation in early experimental polymicrobial sepsis.
Standage SW; Bennion BG; Knowles TO; Ledee DR; Portman MA; McGuire JK; Liles WC; Olson AK
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H239-H249. PubMed ID: 27881386
[TBL] [Abstract][Full Text] [Related]
2. Nonhematopoietic Peroxisome Proliferator-Activated Receptor-α Protects Against Cardiac Injury and Enhances Survival in Experimental Polymicrobial Sepsis.
Standage SW; Waworuntu RL; Delaney MA; Maskal SM; Bennion BG; Duffield JS; Parks WC; Liles WC; McGuire JK
Crit Care Med; 2016 Aug; 44(8):e594-603. PubMed ID: 26757163
[TBL] [Abstract][Full Text] [Related]
3. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
[TBL] [Abstract][Full Text] [Related]
4. Alterations in carbohydrate metabolism and its regulation in PPARalpha null mouse hearts.
Gélinas R; Labarthe F; Bouchard B; Mc Duff J; Charron G; Young ME; Des Rosiers C
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1571-80. PubMed ID: 18223187
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyocyte peroxisome proliferator-activated receptor α prevents septic cardiomyopathy via improving mitochondrial function.
Zhu XX; Wang X; Jiao SY; Liu Y; Shi L; Xu Q; Wang JJ; Chen YE; Zhang Q; Song YT; Wei M; Yu BQ; Fielitz J; Gonzalez FJ; Du J; Qu AJ
Acta Pharmacol Sin; 2023 Nov; 44(11):2184-2200. PubMed ID: 37328648
[TBL] [Abstract][Full Text] [Related]
6. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
7. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
[TBL] [Abstract][Full Text] [Related]
8. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity.
Watanabe K; Fujii H; Takahashi T; Kodama M; Aizawa Y; Ohta Y; Ono T; Hasegawa G; Naito M; Nakajima T; Kamijo Y; Gonzalez FJ; Aoyama T
J Biol Chem; 2000 Jul; 275(29):22293-9. PubMed ID: 10801788
[TBL] [Abstract][Full Text] [Related]
9. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.
Hafstad AD; Khalid AM; Hagve M; Lund T; Larsen TS; Severson DL; Clarke K; Berge RK; Aasum E
Cardiovasc Res; 2009 Aug; 83(3):519-26. PubMed ID: 19398469
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac Function.
Drosatos K; Pollak NM; Pol CJ; Ntziachristos P; Willecke F; Valenti MC; Trent CM; Hu Y; Guo S; Aifantis I; Goldberg IJ
Circ Res; 2016 Jan; 118(2):241-53. PubMed ID: 26574507
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis.
Lehman JJ; Boudina S; Banke NH; Sambandam N; Han X; Young DM; Leone TC; Gross RW; Lewandowski ED; Abel ED; Kelly DP
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H185-96. PubMed ID: 18487436
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of telomere-associated repressor activator protein 1 precipitates cardiac aging in mice
Cai Y; Liu H; Song E; Wang L; Xu J; He Y; Zhang D; Zhang L; Cheng KK; Jin L; Wu M; Liu S; Qi D; Zhang L; Lopaschuk GD; Wang S; Xu A; Xia Z
Theranostics; 2021; 11(10):4710-4727. PubMed ID: 33754023
[No Abstract] [Full Text] [Related]
13. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction.
Drosatos K; Drosatos-Tampakaki Z; Khan R; Homma S; Schulze PC; Zannis VI; Goldberg IJ
J Biol Chem; 2011 Oct; 286(42):36331-9. PubMed ID: 21873422
[TBL] [Abstract][Full Text] [Related]
15. Inorganic nitrate, hypoxia, and the regulation of cardiac mitochondrial respiration-probing the role of PPARα.
Horscroft JA; O'Brien KA; Clark AD; Lindsay RT; Steel AS; Procter NEK; Devaux J; Frenneaux M; Harridge SDR; Murray AJ
FASEB J; 2019 Jun; 33(6):7563-7577. PubMed ID: 30870003
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-γ activation prevents sepsis-related cardiac dysfunction and mortality in mice.
Drosatos K; Khan RS; Trent CM; Jiang H; Son NH; Blaner WS; Homma S; Schulze PC; Goldberg IJ
Circ Heart Fail; 2013 May; 6(3):550-62. PubMed ID: 23572494
[TBL] [Abstract][Full Text] [Related]
17. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cardiac fatty acids metabolism in transgenic mice overexpressing bovine GH.
Bogazzi F; Raggi F; Ultimieri F; Russo D; D'Alessio A; Manariti A; Brogioni S; Manetti L; Martino E
J Endocrinol; 2009 Jun; 201(3):419-27. PubMed ID: 19342398
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
[TBL] [Abstract][Full Text] [Related]
20. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
